MYLAN INSTITUTIONAL FDA Approval NDA 019832

NDA 019832

MYLAN INSTITUTIONAL

FDA Drug Application

Application #019832

Documents

Letter1998-06-05
Letter2001-07-12
Letter2001-07-12
Label1998-06-05
Review1999-01-06

Application Sponsors

NDA 019832MYLAN INSTITUTIONAL

Marketing Status

Prescription003

Application Products

003FOR SOLUTION;TOPICAL5%1SULFAMYLONMAFENIDE ACETATE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1998-06-05STANDARD
LABELING; LabelingSUPPL2AP2001-07-12STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP2001-07-12STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL4AP2001-09-17STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL5AP2002-05-09STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL6AP2002-12-18STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL13AP2013-06-18STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL14AP2015-01-20STANDARD

Submissions Property Types

ORIG1Null25
SUPPL3Null14
SUPPL4Null14
SUPPL5Null14
SUPPL6Null14
SUPPL13Null14
SUPPL14Null14

TE Codes

003PrescriptionAT

CDER Filings

MYLAN INSTITUTIONAL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 19832
            [companyName] => MYLAN INSTITUTIONAL
            [docInserts] => ["",""]
            [products] => [{"drugName":"SULFAMYLON","activeIngredients":"MAFENIDE ACETATE","strength":"5%","dosageForm":"FOR SOLUTION;TOPICAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"06\/05\/1998","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/1998\\\/19832lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"SULFAMYLON","submission":"MAFENIDE ACETATE","actionType":"5%","submissionClassification":"FOR SOLUTION;TOPICAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 1998-06-05
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.